- ... fitness rather than age. 4.1.3. Treating advanced-stage asymptomatic follicular lymphoma Follicular lymphoma has a long natural history. The ... m2 at weekly intervals. 4.1.4. Treating advanced-stage symptomatic follicular lymphoma NICE has developed a suite of technology appraisal ...
- ... with deferred chemotherapy (watch and wait) in treating advanced asymptomatic follicular lymphoma B.1. Background Follicular lymphoma has a long ... of the following management strategies for people with advanced asymptomatic follicular lymphoma: Watchful ... induction Rituximab induction and maintenance ...
- ... chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children' ... Laver JH, Kraveka JM, Hutchison RE, et al.: Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized ...
- ... Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative ... and detection of relapse in intermediate-stage and advanced-stage Hodgkin lymphoma. Most relapses occurred within the first year after ...
- ... Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma ). Funded by Millenium Pharmaceuticals Ltd. No involvement in ... FDG-PET imaging in patients with newly diagnosed, advanced Hodgkin's lymphoma ). Funded by CRUK Non-personal financial Non-specific ...
- ... FDG-PET imaging in patients with newly diagnosed, advanced Hodgkin's lymphoma). Funded by CRUK Non-personal pecuniary, Non-specific ... brentuximab vedotin in the first line treatment of advanced classic Hodgkin lymphoma. Funded by Takeda. Non-personal pecuniary, Non-specific ...
- ... wait) the more effective treatment for people with advanced asymptomatic follicular lymphoma? Literature search details Database name Dates Covered No ...
- ... et al.: Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood 112 (8): 3082- ... is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin ...
- ... in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders) : NCI-COG Pediatric Molecular Analysis ...
- ... in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders) : NCI–Children's Oncology Group ...
826 results